Centre Universitaire de La Réunion
Saint-Pierre, 97448, France
NCT Number: NCT02907970
FOSFORE study aims at identifying the barriers of cervical cancer screening in Reunion Island and key levers for improvment.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Observational
Saint-Pierre, 97448, France
FOSFORE is a cross sectional KABP (Knowledge, Attitudes, Beliefs and Practices) telephone survey on cervical cancer screening from a sounding board of women aged between 25 and 65 years and living in Reunion Island.
Sample size was estimated from local datas on cervical cancer screening.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Telephone survey with a KABP-like questionnaire
Time frame: 6 months
Telephone survey with a KABP-like questionnaire
Time frame: 6 months
Telephone survey with a KABP-like questionnaire
Time frame: 6 months
Telephone survey with a KABP-like questionnaire
Centre Hospitalier Universitaire de la Réunion
Other
Identification Des barrières au dépistage du Cancer du Col utérin à la Réunion et Des Leviers d'amélioration
Acronym: FOSFORE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04557423
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04221945
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Phoenix, Arizona, United States
View Trial DetailsNCT05007106
Adenocarcinoma, Adnexal Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT04694495
Communicable Diseases, DNA Virus Infections
Hefei, Anhui, China
View Trial Details